• Explore /
  • Poster
  • / Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Abstract Poster

Authors

Ranee Mehra

Ranee Mehra

Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD

Ranee Mehra , Yael Flamand , Harry Quon , Joaquin J. Garcia , Gregory S. Weinstein , Umamaheswar Duvvuri , Bert W. O'Malley , Enver Ozer , Giovana R. Thomas , Wayne Koch , Neil D. Gross , Richard Bryan Bell , Nabil F. Saba , Miriam Lango , Rodrigo Bayon , Barbara Burtness , Robert L. Ferris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT01898494

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6077)

DOI

10.1200/JCO.2022.40.16_suppl.6077

Abstract #

6077

Poster Bd #

69

Abstract Disclosures

Similar Posters

First Author: Robert L. Ferris

First Author: Hongyu Pan

First Author: Daniel McGrail

First Author: Jesse Meir Zaretsky